Gretta sells HCP 40.5: HCP's Neutral Rating Reaffirmed at Zacks (HCP) | Ticker Report
Zacks reaffirmed their neutral rating on shares of HCP (NYSE:HCP) in a report released on Wednesday. Zacks currently has a $45.00 price objective on the stock. Zacks ... ...
47 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home